OpenURL Connection Search

Select item for more details and to access through your institution.

Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
Published in:
Heart & Vessels, 2022, v. 37, n. 5, p. 884, doi. 10.1007/s00380-021-01981-1
By:
- Li, Haiyan;
- Shuai, Zongwen
Publication type:
Article
Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity.
Published in:
Journal of Pharmacy Practice, 2024, v. 37, n. 3, p. 632, doi. 10.1177/08971900231158931
By:
- Troyer, Bradley S.;
- Kovacic Scherrer, Nicole;
- Garavaglia, Jeffrey
Publication type:
Article
COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations.
Published in:
Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 407, doi. 10.1177/08971900211048139
By:
- Nhean, Salin;
- Varela, Mario E.;
- Nguyen, Y-Nha;
- Juarez, Alejandra;
- Huynh, Tuyen;
- Udeh, Darlington;
- Tseng, Alice L.
Publication type:
Article
Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.
Published in:
Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 213, doi. 10.1177/08971900211028208
By:
- Raja, Karan;
- Daniel, Nicole;
- Morrison, Susan;
- Patel, Ruben;
- Gerges, Jessica;
- Nadeem, Komal;
- Chen, Brandon;
- Kang, Soo;
- Patel, Mitesh;
- Beggs, Donald;
- Attalla, Mark;
- Ballem, Naveen;
- Philips, Mona
Publication type:
Article
Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection.
Published in:
Journal of Pharmacy Practice, 2022, v. 35, n. 5, p. 752, doi. 10.1177/08971900211000691
By:
- Meanwatthana, Jennis;
- Majam, Teerapat
Publication type:
Article
Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.
Published in:
Journal of Pharmacy Practice, 2022, v. 35, n. 4, p. 587, doi. 10.1177/08971900211002353
By:
- McKenzie, Matt G.;
- Lee, Yeunju;
- Mathew, Julin;
- Anderson, Megan;
- Vo, Alison T.;
- Akinyele, Samuel;
- Narayanan, Malarvizhi
Publication type:
Article
Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman.
Published in:
Health Services Research & Managerial Epidemiology, 2021, v. 8, p. 1, doi. 10.1177/2333392820986639
By:
- Al Harthi, Saud;
- Osali, Magdi Al;
- Kindi, Nasser Al;
- Kharusi, Zahir Al;
- Qasabi, Salim Al;
- Hinai, Mohamed Al;
- Ghafri, Thamra Al
Publication type:
Article
Modeling the Effect of Tocilizumab on The Case Fatality Rate In Patients With Severe Covid-19.
Published in:
International Journal of Pharmaceutical Research (09752366), 2020, p. 1984, doi. 10.31838/ijpr/2020.SP1.292
By:
- ZHUKOVA, OLGA V.;
- KHOKHLOV, ALEXANDER L.
Publication type:
Article
TAFRO syndrome mimicking solid cancer and successfully treated by tocilizumab: A case and literature review.
Published in:
Journal of Cancer Research & Practice, 2023, v. 10, n. 4, p. 161, doi. 10.4103/ejcrp.eJCRP-D-23-00021
By:
- Fu, Pei-An;
- Wu, Chia-Chi;
- Hsu, Ya-Ting
Publication type:
Article
Tocilizumab treatment in MOGAD: a case report and literature review.
Published in:
Neurological Sciences, 2024, v. 45, n. 4, p. 1429, doi. 10.1007/s10072-023-07189-7
By:
- Schirò, Giuseppe;
- Iacono, Salvatore;
- Andolina, Michele;
- Bianchi, Alessia;
- Ragonese, Paolo;
- Salemi, Giuseppe
Publication type:
Article
Use of tocilizumab for treatment of COVID-19 from off-label to extended indication.
Published in:
Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 579, doi. 10.33320/maced.pharm.bull.2022.68.03.277
By:
- Velevska, Iskra;
- Aleksov, Jovana;
- Mihajloska, Evgenija;
- Dimkovski, Aleksandar;
- Panovska-Stavridis, Irina;
- Stevanovic, Milena;
- Grozdanova, Aleksandra
Publication type:
Article
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death.
Published in:
Healthcare (2227-9032), 2023, v. 11, n. 7, p. 1025, doi. 10.3390/healthcare11071025
By:
- Al. Kharusi, Mardheya;
- Al Sheikh, Naffesa;
- Alhajri, Maiya;
- Al. Mandhri, Seif Ali;
- Khafagy, El-Sayed;
- Moglad, Ehssan H.;
- Alotaibi, Hadil Faris;
- Hegazy, Wael A. H.
Publication type:
Article
Possible immuno-modulatory effects of tocilizumab in patients with refractory status epilepticus.
Published in:
European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 4, p. 1512
By:
- EL-HAGGAR, S. M.;
- HEGAZY, S. K.;
- MUSTAFA, W.;
- KHRIEBA, M. O.
Publication type:
Article
Corticosteroids, mortality and mechanical ventilation in COVID-19.
Published in:
British Journal of Community Nursing, 2021, v. 26, n. 2, p. 100, doi. 10.12968/bjcn.2021.26.2.100
By:
- Mendes, Aysha
Publication type:
Article
A successful antenatal outcome in a patient with refractory Takayasu's arteritis treated with tocilizumab throughout pregnancy—a case report.
Published in:
Oxford Medical Case Reports, 2023, v. 2023, n. 5, p. 1, doi. 10.1093/omcr/omad046
By:
- Khan, Behram;
- David, Trixy;
- Sussman, Jon;
- Simcox, Louise;
- Tower, Clare;
- Soh, Calvin;
- Bruce, Ian N
Publication type:
Article
Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy.
Published in:
2016
By:
- Nadesalingam, Kavitha;
- Goodfield, Mark;
- Emery, Paul
Publication type:
Case Study
Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
Published in:
Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofab013
By:
- Klopfenstein, Timothée;
- Conrozier, Thierry;
- Kadiane-Oussou, N'dri Juliette;
- Gendrin, Vincent;
- Zayet, Souheil
Publication type:
Article
Impact of Interleukin-6 Receptor Blockade With Tocilizumab on Cardiac Injury in Patients With COVID-19: A Retrospective Cohort Study.
Published in:
Open Forum Infectious Diseases, 2021, v. 8, n. 2, p. 1, doi. 10.1093/ofid/ofab012
By:
- Weber, Brittany N;
- Zhou, Guohai;
- Kim, Andy;
- Pearson, Jeffrey C;
- Stone, John;
- DiCarli, Marcelo;
- Nikiforow, Sarah;
- Woolley, Ann
Publication type:
Article
Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis.
Published in:
Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa598
By:
- Ignatius, Elisa H;
- Wang, Kunbo;
- Karaba, Andrew;
- Robinson, Matthew;
- Avery, Robin K;
- Blair, Paul;
- Chida, Natasha;
- Jain, Tania;
- Petty, Brent G;
- Siddiqui, Zishan;
- Melia, Michael T;
- Auwaerter, Paul G;
- Xu, Yanxun;
- Garibaldi, Brian T
Publication type:
Article
Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab.
Published in:
BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/4926168
By:
- Miao, Shiwei;
- Fan, Li;
- Zhao, Liang;
- Ding, Ding;
- Liu, Xiaohui;
- Wang, Haibin;
- Tan, Wen-Song
Publication type:
Article
P1‐65: Two cases of Castleman's disease with lung lesions controlled by tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 100, doi. 10.1111/resp.14150_65
Publication type:
Article
P5‐76: Prolonged viral clearance in COVID‐19 patients treated with tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 187, doi. 10.1111/resp.14150_283
Publication type:
Article
P5‐122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID‐19 treatment with systemic corticosteroid and tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 207, doi. 10.1111/resp.14150_329
Publication type:
Article
P5‐58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID‐19.
Published in:
Respirology, 2021, v. 26, p. 180, doi. 10.1111/resp.14150_265
Publication type:
Article
P1‐65: Two cases of Castleman's disease with lung lesions controlled by tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 100, doi. 10.1111/resp.14150_65
Publication type:
Article
P5‐122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID‐19 treatment with systemic corticosteroid and tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 207, doi. 10.1111/resp.14150_329
Publication type:
Article
P5‐97: High‐dose methylprednisolone in combination with tocilizumab in hospitalized patients with critical COVID‐19 pneumonia: A case series.
Published in:
Respirology, 2021, v. 26, p. 196, doi. 10.1111/resp.14150_304
Publication type:
Article
P5‐76: Prolonged viral clearance in COVID‐19 patients treated with tocilizumab.
Published in:
Respirology, 2021, v. 26, p. 187, doi. 10.1111/resp.14150_283
Publication type:
Article
P5‐58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID‐19.
Published in:
Respirology, 2021, v. 26, p. 180, doi. 10.1111/resp.14150_265
Publication type:
Article
Tocilizumab administration for the treatment of hospitalized patients with COVID‐19: A systematic review and meta‐analysis.
Published in:
Respirology, 2021, v. 26, n. 11, p. 1027, doi. 10.1111/resp.14152
By:
- Kyriakopoulos, Christos;
- Ntritsos, Georgios;
- Gogali, Athena;
- Milionis, Haralampos;
- Evangelou, Evangelos;
- Kostikas, Konstantinos
Publication type:
Article
Severe COVID‐19 and interleukin‐6 receptor antagonist tocilizumab: Some notes of concern.
Published in:
Respirology, 2020, v. 25, n. 11, p. 1209, doi. 10.1111/resp.13939
By:
- Akinosoglou, Karolina;
- Gogos, Charalambos
Publication type:
Article
Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state.
Published in:
Respirology, 2020, v. 25, n. 10, p. 1090, doi. 10.1111/resp.13912
By:
- McCarthy, Cormac;
- Savinelli, Stefano;
- Feeney, Eoin R.;
- Butler, Marcus W.;
- O'Broin, Cathal;
- Ryan, Silke;
- O'Neill, Lorraine;
- Murphy, David J.;
- Gallagher, Charles G.;
- McKone, Edward F.;
- Waqas, Sarmad;
- Cotter, Aoife;
- Doran, Peter;
- Keane, Michael P.;
- Mallon, Patrick W.
Publication type:
Article
Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01048-0
By:
- Costa, Bruno Almeida;
- Flynn, Jessica;
- Nishimura, Noriko;
- Devlin, Sean M.;
- Farzana, Tasmin;
- Rajeeve, Sridevi;
- Chung, David J.;
- Landau, Heather J.;
- Lahoud, Oscar B.;
- Scordo, Michael;
- Shah, Gunjan L.;
- Hassoun, Hani;
- Maclachlan, Kylee;
- Hultcrantz, Malin;
- Korde, Neha;
- Lesokhin, Alexander M.;
- Shah, Urvi A.;
- Tan, Carlyn R.;
- Giralt, Sergio A.;
- Usmani, Saad Z.
Publication type:
Article
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00963-y
By:
- Scott, Sara A.;
- Marin, Ellen M.;
- Maples, Kathryn T.;
- Joseph, Nisha S.;
- Hofmeister, Craig C.;
- Gupta, Vikas A.;
- Dhodapkar, Madhav V.;
- Kaufman, Jonathan L.;
- Lonial, Sagar;
- Nooka, Ajay K.
Publication type:
Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
By:
- Camon, Ana M.;
- Alonso, Rodrigo;
- Muñoz, Francisco J.;
- Cardozo, Celia;
- Bernal-Maurandi, Javier;
- Albiach, Laia;
- Agüero, Daiana;
- Marcos, M. Angeles;
- Ambrosioni, Juan;
- Bodro, Marta;
- Chumbita, Mariana;
- De la Mora, Lorena;
- Garcia-Pouton, Nicole;
- Dueñas, Gerard;
- Hernandez-Meneses, Marta;
- Inciarte, Alexy;
- Cuesta, Genoveva;
- Meira, Fernanda;
- Morata, Laura;
- Puerta-Alcalde, Pedro
Publication type:
Article
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08882-x
By:
- Camon, Ana M.;
- Alonso, Rodrigo;
- Muñoz, Francisco J.;
- Cardozo, Celia;
- Bernal-Maurandi, Javier;
- Albiach, Laia;
- Agüero, Daiana;
- Marcos, M. Angeles;
- Ambrosioni, Juan;
- Bodro, Marta;
- Chumbita, Mariana;
- De la Mora, Lorena;
- Garcia-Pouton, Nicole;
- Dueñas, Gerard;
- Hernandez-Meneses, Marta;
- Inciarte, Alexy;
- Cuesta, Genoveva;
- Meira, Fernanda;
- Morata, Laura;
- Puerta-Alcalde, Pedro
Publication type:
Article
Tocilizumab reduces COVID-19 mortality and pathology in a dose and timing-dependent fashion: a multi-centric study.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99291-z
By:
- Durán-Méndez, Alejandro;
- Aguilar-Arroyo, Alma Delia;
- Vivanco-Gómez, Emiliano;
- Nieto-Ortega, Eduardo;
- Pérez-Ortega, Daniela;
- Jiménez-Pérez, Cristian;
- Hernández-Skewes, Karla Y.;
- Montiel-Bravo, Guillermo;
- Roque-Reyes, Oscar J.;
- Romero-Lechuga, Fernanda;
- Medina-Santos, Diana;
- Oriana-Román, Perla;
- Flores-Hernández, Jorge Rafael;
- Méndez-Coca, Juan Daniel;
- Montaño-Olmos, Daniela;
- Farfán-Lazos, Karla Cecilia;
- Tobón-Cubillos, Miranda;
- Viveros-Hernández, América;
- Sevilla-Castillo, Fernando;
- Hernández-Romero, Ángel Raúl
Publication type:
Article
Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98325-w
By:
- Kamath, Ashwin;
- Acharya, Sahana D.;
- Rao, Rashmi R.;
- Ullal, Sheetal D.
Publication type:
Article
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis.
Published in:
Journal of Personalized Medicine, 2023, v. 13, n. 1, p. 61, doi. 10.3390/jpm13010061
By:
- Sainz, Luis;
- Riera, Pau;
- Moya, Patricia;
- Bernal, Sara;
- Casademont, Jordi;
- Díaz-Torné, Cesar;
- Millán, Ana Milena;
- Park, Hye Sang;
- Lasa, Adriana;
- Corominas, Héctor
Publication type:
Article
Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants.
Published in:
Journal of Personalized Medicine, 2022, v. 12, n. 7, p. 1103, doi. 10.3390/jpm12071103
By:
- Oliynyk, Oleksandr;
- Barg, Wojciech;
- Oliynyk, Yanina;
- Dubrov, Serhij;
- Gurianov, Vitaliy;
- Rorat, Marta
Publication type:
Article
Intensive Care Patients from the First COVID-19 Wave: One-Year Survival after Tocilizumab Treatment.
Published in:
Journal of Personalized Medicine, 2021, v. 11, n. 11, p. 1234, doi. 10.3390/jpm11111234
By:
- Melegari, Gabriele;
- Giuliani, Enrico;
- Dallai, Chiara;
- Veronesi, Lucia;
- Bertellini, Elisabetta;
- Osmenaj, Suela;
- Barbieri, Alberto
Publication type:
Article
Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis.
Published in:
Journal of Personalized Medicine, 2021, v. 11, n. 7, p. 628, doi. 10.3390/jpm11070628
By:
- Conti, Valeria;
- Corbi, Graziamaria;
- Sellitto, Carmine;
- Sabbatino, Francesco;
- Maci, Chiara;
- Bertini, Nicola;
- De Bellis, Emanuela;
- Iuliano, Antonio;
- Davinelli, Sergio;
- Pagliano, Pasquale;
- Filippelli, Amelia
Publication type:
Article
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.
Published in:
Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1195, doi. 10.1007/s40121-021-00488-6
By:
- Klopfenstein, Timothée;
- Gendrin, Vincent;
- Gerazime, Aurélie;
- Conrozier, Thierry;
- Balblanc, Jean-Charles;
- Royer, Pierre-Yves;
- Lohse, Anne;
- Mezher, Chaouki;
- Toko, Lynda;
- Guillochon, Cerise;
- Badie, Julio;
- Pierron, Alix;
- Kadiane-Oussou, N.'dri Juliette;
- Puyraveau, Marc;
- Zayet, Souheil
Publication type:
Article
Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis.
Published in:
Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1677, doi. 10.1007/s40121-021-00483-x
By:
- Jiang, Weijun;
- Li, Weiwei;
- Wu, Qiuyue;
- Han, Ying;
- Zhang, Jing;
- Luo, Tao;
- Guo, Yanju;
- Yang, Yang;
- Zhu, Peiran;
- Xia, Xinyi
Publication type:
Article
A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort.
Published in:
2021
By:
- Ruiz-Antorán, Belén;
- Sancho-López, Aránzazu;
- Torres, Ferrán;
- Fernández-Cruz, Ana
Publication type:
Letter
Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.
Published in:
2021
By:
- Janapala, Rajesh Naidu;
- Patel, Jigar;
- Belfaqeeh, Omar;
- Alhashmi, Abdulla;
- Pourmand, Ali
Publication type:
Letter
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.
Published in:
Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 347, doi. 10.1007/s40121-020-00373-8
By:
- Ruiz-Antorán, Belén;
- Sancho-López, Aránzazu;
- Torres, Ferrán;
- Moreno-Torres, Víctor;
- de Pablo-López, Itziar;
- García-López, Paulina;
- Abad-Santos, Francisco;
- Rosso-Fernández, Clara M.;
- Aldea-Perona, Ana;
- Montané, Eva;
- Aparicio-Hernández, Ruth M.;
- Llop-Rius, Roser;
- Pedrós, Consuelo;
- Gijón, Paloma;
- Hernández-Carballo, Carolina;
- Pedrosa-Martínez, María J.;
- Rodríguez-Jiménez, Consuelo;
- Prada-Ramallal, Guillermo;
- Cabrera-García, Lourdes;
- Aguilar-García, Josefa A.
Publication type:
Article
LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects.
Published in:
Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1111893
By:
- Guoying Cao;
- Jingjing Wang;
- Jinjie He;
- Yingying Hu;
- Haijing Yang;
- Linling Que;
- Xianghong Gu;
- Jicheng Yu;
- Xiaojie Wu;
- Jufang Wu;
- Wei Fang;
- Qing He;
- Jing Zhang
Publication type:
Article
Tocilizumab and COVID-19: Timing of Administration and Efficacy.
Published in:
Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.825749
By:
- Abidi, Emna;
- El Nekidy, Wasim S.;
- Alefishat, Eman;
- Rahman, Nadeem;
- Petroianu, Georg A.;
- El-Lababidi, Rania;
- Mallat, Jihad
Publication type:
Article
Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma.
Published in:
Case Reports in Oncological Medicine, 2021, p. 1, doi. 10.1155/2021/5532258
By:
- Sabe, Hideaki;
- Inoue, Akitomo;
- Nagata, Shigenori;
- Imura, Yoshinori;
- Wakamatsu, Toru;
- Takenaka, Satoshi;
- Tamiya, Hironari
Publication type:
Article

Found: 1145